EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapies for Mitochondrial Disease: Past, Present, and Future

Megan Ball iD, Nicole J van Bergen, Alison G Compton, David R Thorburn, Shamima Rahman, John Christodoulou

Journal of Inherited Metabolic Disease · 2025-07 · 48 (4)

DOI: 10.1002/jimd.70065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 25.07.2025. Verfasst von Megan Ball und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Melbourne, Australia. Hauptthemen laut MEDLINE: Mitochondrial Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 260 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victorian Government's Operational Infrastructure Support Program, Royal Children's Hospital Foundation, Mito Foundation, PhD Top Up Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial disease is a diverse group of clinically and genetically complex disorders caused by pathogenic variants in nuclear or mitochondrial DNA‐encoded genes that disrupt mitochondrial energy production or other important mitochondrial pathways. Mitochondrial disease can present with a wide spectrum of clinical features and can often be difficult to recognize. These conditions can be devastating; however, for the majority, there is no targeted treatment. In the last 60 years, mitochondrial medicine has experienced significant evolution, moving from the pre‐molecular era to the Age of Genomics in which considerable gene discovery and advancement in our understanding of the pathophysiology of mitochondrial disease have been made. In the last decade, in response to the urgent need for effective treatments, a wide range of emerging therapies have been developed, driven by innovative approaches addressing both the genetic and cellular mechanisms underpinning the diseases. Emerging therapies include dietary intervention, small molecule therapies aimed to restore mitochondrial function, stem cell or liver transplantation, and gene or RNA‐based therapies. However, despite these advances, translation to clinical practice is complicated by the sheer genetic and clinical complexity of mitochondrial disease, difficulty in efficient and precise delivery of therapies to affected tissues, rarity of individual genetic conditions, lack of reliable biomarkers and clinically relevant outcome measures, and the dearth of natural history data. This review examines the latest developments in the pursuit to identify effective treatments for mitochondrial disease and discusses the barriers impeding their success in translation to clinical practice. While treatment for mitochondrial disease may be on the horizon, many challenges must be addressed before it can become a reality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial DiseasesHumansGenetic TherapyMitochondriaDNA, Mitochondrial

Stichwörter der Autor:innen

clinical trialsgene therapymitochondrial diseasesmall molecule therapytreatment

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Department of Paediatrics, University of Melbourne, Melbourne, Australia.
  • Royal Children's Hospital, Melbourne, Australia.
  • Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.
  • Metabolic Unit, Great Ormond Street Hospital, London, UK.
  • Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, London, UK.

ORCID-Profile: Megan Ball

Förderung

  • Victorian Government's Operational Infrastructure Support Program
  • Royal Children's Hospital Foundation
  • Mito Foundation, PhD Top Up Scholarship
  • Melbourne Academic Centre for Health, Clinician-Researcher Scholarship
  • VESKI Near-miss Award Pilot
  • Australian National Health and Medical Research Council
  • Medical Research Future Fund
  • Horizon Medicine

Zitieren

APA

Ball, M., van Bergen, N. J., Compton, A. G., Thorburn, D. R., Rahman, S., & Christodoulou, J. (2025). Therapies for Mitochondrial Disease: Past, Present, and Future. Journal of Inherited Metabolic Disease, 48(4). https://doi.org/10.1002/jimd.70065

Vancouver

Ball M, van Bergen NJ, Compton AG, Thorburn DR, Rahman S, Christodoulou J. Therapies for Mitochondrial Disease: Past, Present, and Future. Journal of Inherited Metabolic Disease. 2025;48(4). doi:10.1002/jimd.70065

BibTeX
@article{Ball2025,
  author = {Ball, Megan and van Bergen, Nicole J and Compton, Alison G and Thorburn, David R and Rahman, Shamima and Christodoulou, John},
  title = {Therapies for Mitochondrial Disease: Past, Present, and Future},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  volume = {48},
  number = {4},
  doi = {10.1002/jimd.70065}
}
Kostenlos starten →